Madrid, Spain

Luis Santos

This inventor holds 3 USPTO granted patents. Top assignees: Alter, S.a., Other. Active years: 1993-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Luis Santos

Introduction

Luis Santos is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of chemistry, particularly in the development of new pharmaceutical compounds. With a total of 3 patents to his name, Santos has focused on creating innovative solutions for medical treatments.

Latest Patents

Santos's latest patents include the development of 1,4-dihydropyridine derivatives, which are crucial for treating hypertension. These compounds exhibit a vasodilatory effect, making them suitable for managing high blood pressure. Additionally, some of these compounds have a vasoconstrictory effect, which can be beneficial in treating hypotension. Another significant patent involves 1,4-dihydropyridine compounds with PAF-antagonistic activity. These compounds are designed to treat various pathologic states and disorders, including inflammatory processes and immunodeficient syndromes.

Career Highlights

Throughout his career, Luis Santos has worked with various companies, including Alter, S.A. His work has been instrumental in advancing pharmaceutical research and development. His innovative approach has led to the creation of compounds that address critical health issues.

Collaborations

Santos has collaborated with notable professionals in his field, including Carlos Sunkel and Miguel Fau De Casa-Juana. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Luis Santos is a distinguished inventor whose work in developing pharmaceutical compounds has made a significant impact on medical treatments. His innovative contributions continue to advance the field of chemistry and improve patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…